Close Menu
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
Facebook X (Twitter) Instagram
Facebook LinkedIn
Financial Market News
Subscribe Now
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
Financial Market News
You are at:Home»Posts Tagged "weight"

What’s next for the weight loss drug market: pills, rivals, insurance

By FinMar NewsNovember 2, 2025

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | ReutersThe…

FDA approves Signos glucose monitoring for weight loss

By FinMar NewsAugust 20, 2025

Woman with Signos wearable and appSource: SignosThe Food and Drug Administration on Wednesday approved the first-ever glucose monitoring system specifically for weight loss from the startup…

Investors pour billions into S&P equal weight fund as tech fears rise

By FinMar NewsJanuary 15, 2025

Stay informed with free updatesSimply sign up to the US equities myFT Digest — delivered directly to your inbox.Investors have poured record amounts of money into…

FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea

By FinMar NewsDecember 21, 2024

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. Shelby Knowles | Bloomberg |…

GLP-1 weight loss boom spurs protein sales, Vitamin Shoppe says

By FinMar NewsJune 11, 2024

The weight loss boom is pushing consumers to spend more on protein supplement products.That’s according to new data from The Vitamin Shoppe’s 2024 Health & Wellness…

Weight loss drug ETF bets big on Eli Lilly, Novo Nordisk

By FinMar NewsMay 27, 2024

A top exchange-traded fund provider is betting on the long-term popularity of GLP-1 weight loss drugs.Roundhill Investments’ GLP-1 & Weight Loss ETF (OZEM), which began trading…

Amgen soars on weight loss drug progress, Novo Nordisk, Eli Lilly slide

By FinMar NewsMay 3, 2024

Amgen’s stock rose more than 12% on Friday after the drugmaker teased positive initial data on its experimental weight loss injection. That fueled investor concerns about new…

Weight loss drug patients spend less on restaurants, takeout: survey

By FinMar NewsApril 20, 2024

A food delivery messenger carries a take out bag outside aSweetgreen in Manhattan on September 14, 2023.Jeenah Moon | The Washington Post | Getty ImagesA highly…

Wegovy’s heart benefits are not just linked with weight loss, new study

By FinMar NewsApril 6, 2024

People with obesity-related heart failure and diabetes can get substantial heart-health benefits from weight-loss drug Wegovy, even if they don’t shed many pounds on the medication,…

Energy News

Oil prices hold steady due to stalled Ukraine peace talks and supply

Tying Together a Diverse Energy and Retail Environment

Inside Neo’s rare earths factory

‘Renewable’ No More: The Trump Administration Renames the National

Banks News

Gulf Bank continues investing in technology and elevating customer

US Bank Regulators Ease Post-Crisis Curbs on Leveraged Loans

Temenos named Best Core Banking System at Banking Tech Awards 2025

Banks hoping to gain new clients in Minnesota after recent acquisitions

Real Estate News

Tompkins County real estate: 10 most expensive homes sold, Nov. 29-Dec. 5

This Week in Review | Cryptocurrency Volatility, Global Inflation, Real

Real Estate Decarbonization Is Moving to the Building Level

Agents Find a ‘Green Advantage’ in Commercial Real Estate

© 2025 finmar.news

Type above and press Enter to search. Press Esc to cancel.

Social Media Auto Publish Powered By : XYZScripts.com
[newsletter-pack newsletter='24']